Neurocrine Biosciences (NBIX) Cash & Equivalents Growth (3y) (2013 - 2026)
Neurocrine Biosciences (NBIX) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 20.41% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -2.73% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 3.22% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -49.65% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 36.93% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 10.41% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 3.03% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 1.92% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 65.82% |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 33.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.93% |
| Dec 31, 2025 | 38.10% |
| Sep 30, 2025 | 17.04% |
| Jun 30, 2025 | 17.37% |
| Mar 31, 2025 | -10.44% |
| Dec 31, 2024 | -12.18% |
| Sep 30, 2024 | 3.92% |
| Jun 30, 2024 | -27.59% |
| Mar 31, 2024 | 3.97% |
| Dec 31, 2023 | 10.83% |
| Sep 30, 2023 | -11.61% |
| Jun 30, 2023 | -27.19% |
| Mar 31, 2023 | -17.82% |
| Dec 31, 2022 | 34.08% |
| Sep 30, 2022 | 8.39% |
| Jun 30, 2022 | 5.02% |
| Mar 31, 2022 | 54.84% |
| Dec 31, 2021 | 34.39% |
| Sep 30, 2021 | 16.70% |
| Jun 30, 2021 | 30.28% |